BioClec
PrivateLast Round
Seed
Mar 18, 2025
Company Overview
BioClec operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Seed round in March 2025.
BioClec is a biotechnology company developing therapies for Alzheimer's disease by targeting microglia, the brain's immune cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioClec Comparables
Compare BioClec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monument Biosciences | 86% | |
| Vigil Neuro | 77% | |
| Modulo Bio | 77% |
For institutional investors. Book with your work email.
BioClec Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
BioClec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sofinnova Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2025
Led by Sofinnova Partners.
For institutional investors. Book with your work email.
BioClec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioClec's valuation, stock price, and market status.
Is BioClec a public or private company?
BioClec is a private company.
What is the current stock price of BioClec?
BioClec is a private company, so its shares have no public market price. Caplight tracks BioClec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioClec worth (valuation)?
Valuation information for BioClec is not publicly available.
Can I buy BioClec stock?
BioClec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioClec's last funding round?
BioClec's most recent funding round was Seed on March 18, 2025.
Who are the main investors in BioClec?
Key investors in BioClec include Sofinnova Partners.
Will BioClec IPO soon?
No public IPO plans have been announced for BioClec.
How can I track BioClec secondary market activity?
Caplight tracks bids, offers, and trades in BioClec's shares on secondary markets.